US$ 29.36
contraindications to glp 1 agonists for switching Benefits and Risks of GLP-1
Description
Not approved for diagnostic, therapeutic, or medical applications

Across studies, fat mass decline predominated, whereas reductions in lean body mass were modest

There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis.

About one in eight adults (12%) say they have taken one of an increasingly popular class of prescription drugs known as GLP-1s that are used for weight loss and to treat diabetes and reduce the risk of heart disease and stroke, a new KFF Health Tracking Poll finds.

Rotate placement daily to keep skin happy

This Comment highlights emerging evidence and advocates for clinical strategies that prioritize muscle preservation to ensure the long-term success and safety of pharmacological weight management.
